Online Learning Portal
DAILY NEWS ANALYSIS
06 July, 2020
5 Min Read
Surely, even if slowly: On a COVID-19 vaccine
Context
* A letter by the ICMR’s head, Dr. Balram Bhargava, to doctors last week, preparing to test a vaccine for human trials, appeared to be coercing them into getting a vaccine ready by August 15.
Issues in hastening the process of vaccine trials
* However, there was no rationale extended for why the date August 15 cropped up.
* Given the crisis at hand, regulatory agencies the world over have relaxed rules on drug testing and vaccine trials.
* This is why drugs such as remdesivir and favipiravir — despite limited evidence of success — have made it to the bedside of patients.
Important checkpoints in the vaccine development
* Vaccines are an entirely different game. The basic philosophy of all vaccines involves introducing fragments — in some cases the whole virus, albeit in a weakened form — into healthy volunteers.
1. Therefore, the first checkpoint is that the vaccine candidate should not sicken a healthy person.
2. The second hurdle is that a vaccine must stimulate the immune system just enough to get it to produce protective antibodies. In other words, it must be efficacious and finally, only if all were to go well, it must be tested in several thousand people in real world conditions.
3. And they must be shown, over time, to be better protected than those who were unvaccinated.
* Each one of these steps is necessary to ensure that the vaccine can be released for public use.
* The Hyderabad-based Bharat Biotech, the makers of ‘Covaxin’, has experience and credibility in vaccine manufacture.
* ‘Covaxin’ is developed from a strain of SARS-CoV-2 isolated at NIV. However, this only makes it one of hundreds of potential vaccines being tested and the consensus of experts is that no vaccine can be readied for use until next year.
Way ahead
* Till the development of vaccine, the behavioural changes on social distancing and an insistence on wearing masks in public.
* The pandemic has brought into focus the unavoidable role of uncertainty. New aspects of the disease are being brought to light, sometimes every day. The best strategy, in the midst of such flux, is to maintain absolute transparency, and proceed surely, even if slowly.
Source: TH
A year after tensions arising from Operation Sindoor, India and Azerbaijan have taken steps to restore and normalise bilateral relations. The 6th round of Foreign Office Consultations, held in Baku, marked the first such engagement since 2022, signaling renewed diplomatic momentum. Recent Diplomatic Engagement During the consultations, bo
The India–Australia Economic Cooperation and Trade Agreement has completed four years since its signing. Both countries now aim to build on this progress through strengthened collaboration and ambitious targets, including reaching AUD 100 billion in bilateral trade by 2030. What is the India–Australia Economic Cooperation and Tra
A recent report by the Association for Democratic Reforms (ADR) analyses donations of ?20,000 or more declared to the Election Commission of India (ECI) by national political parties for FY 2024–25, highlighting transparency and accountability in political financing. Key Findings Massive Funding Surge Total donations to nationa
Maritime chokepoints are narrow channels along global shipping routes where maritime traffic is concentrated. These points are geopolitically and economically critical, as they handle a large proportion of global trade, especially energy shipments. Current Relevance Over two-thirds of seaborne energy trade passes through a handful o
Following the launch of Operation Epic Fury (U.S.) and Operation Roaring Lion (Israel), the geopolitical landscape has shifted fundamentally with the confirmed death of Iran’s Supreme Leader, Ayatollah Ali Khamenei.Iran retaliated through Operation True Promise 4, launching missile attacks against Israel and nearby Gulf states. The escala
Our Popular Courses
Module wise Prelims Batches
Mains Batches
Test Series